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Objectives: Myxomatous disease represents the most common cause of
MR due to bileaﬂet prolapse. Mitral valve repair of mitral regurgita-
tion (MR) due to bileaﬂet prolapse poses many technical challenges.
In addition, late outcomes following repair are not well characterized
in this population. Published series have included mixed patient
cohorts and/or lacked long-term echocardiographic follow-up. And
thus constitutes the focus of the current study.
Methods: One-hundred thirty six patients (mean age 57.3 ± 17.5 years)
underwent mitral valve repair of bileaﬂet prolapse due to myxomatous
disease from 2002–2010. Concomitant CABG was performed in 16
(12%) patients. All patients were followed by a dedicated mitral valve
clinic with a follow-up interval that extended up to 6.6 years.
Results: There were no hospital deaths. Ring annuloplasty was used
for all patients. Additional mitral valve repair techniques included
chordal transfer (N ¼ 67), polytetraﬂuoroethylene neochords
(N ¼ 22), edge-to-edge repair, including lateral edge-to-edge repair
towards either commissure (N ¼ 30), or use of the hybrid-ﬂip over
technique (N ¼ 23). Prolapse involving more than one scallop of the
posterior leaﬂet was observed in 32 (24%) patients whereas prolapse
of more than one scallop of the anterior leaﬂet was observed in 56
(41%) patients. At follow-up, 3 patients had MRP2+, and no
patients required subsequent mitral valve re-intervention. Five-year
survival and freedom from recurrent (P2+) MR were 81.9 ± 2.7%
and 95.8 ± 2.7%, respectively.
Conclusions: Mitral valve repair of bileaﬂet prolapse due to myxoma-
tous disease is safe and durable. Successful repair often requires a com-
bination of surgical repair techniques.
http://dx.doi.org/10.1016/j.ehj.2013.12.050
Percutaneous mitral repair with-mitraclip system, safety and eﬃcacy;
initial Egyptian experience
Hazem Khamis, Ahmed Abdelaziz.
Objectives: To evaluate the feasibility, eﬃcacy, and safety of the
MitraClip system in patients with severe MR.
Background: Mitral valve repair for mitral regurgitation (MR) has
been performed by the use of a surgically created double oriﬁce.
Percutaneous repair based on this surgical approach has been
developed by use of the MitraClip device to secure the mitral
leaﬂets.
Methods: Five Patients with 3 to 4+ MR were selected in accordance
with the American Heart Association/American College of Cardiology
guidelines between March 2013 and May 2013 and underwent percuta-
neous mitral repair with MitraClip system . Patients were followed up
for six months after procedure. The primary acute safety endpoint was
freedom from major adverse events (MAEs) at 30 days, deﬁned as the
composite of death, myocardial infarction, non-elective cardiac sur-
gery for adverse events, renal failure, transfusion of more than 2 units
of blood, ventilation for more than 48 h, deep wound infection, septi-
cemia. The primary eﬃcacy endpoint is acute device success deﬁned as
clip implant with reduction of MR to equal or less than grade II, based
on current guidelines.
Results: A total of 5 patients were treated. No patients (0%) had a
major adverse event,. Freedom from clip embolization was 100%. Par-
tial clip detachment had not occurred in any patients (0%) patients.
Overall, 4 of 5 (80%) patients achieved acute procedural success,
and 3 (60%) were discharged with MR of 61+.
Conclusions: Our initial results with the MitraClip device in a very
small number of patients indicate that percutaneous edge-to edge
mitral valve repair is feasible and may be accomplished with favorable
short-term safety and eﬃcacy results.
http://dx.doi.org/10.1016/j.ehj.2013.12.051
Prediction of peri-procedural myocardial injury in patients undergoing
percutaneous coronary intervention by syntax score
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Background: Percutaneous coronary intervention (PCI) is well estab-
lished procedure for management of coronary artery disease. However,
up to 50% of cases associated with myocardial injury with subsequent
increased mortality. Currently there is no reliable method to predict
this injury.
Aim of the work: to investigate the ability of the syntax score to
predict peri-procedure myocardial injury (PMI) in patients undergo-
ing PCI. Patients and Methods: This study included 60 patients.
They are divided into two groups (1 = Non-diabetics) and
(2 = Diabetics) and subjected to: History and physical examination,
ECG, echocardiography, calculation of syntax score, PCI and tro-
ponin T.
Results: Our study shows highly signiﬁcant elevation in the troponin
level in both groups after PCI, this elevation was more in group (2)
(<0.001). In all study population the incidence of PMI was low in
patients with low syntax score and increased proportionally with the
increase in syntax score. We found the syntax score cutoﬀ value for
prediction of PMI to be 15 with calculated sensitivity of 95.3%,
speciﬁcity 88.2%, predictive value positive 95.3% and Predictive value
negative 88.2%.
Conclusion: Syntax score has the ability to predict the occurrence of
PMI with accepted sensitivity. It can assess the patient risk for
development of PMI which could help to rationalize the use of
adjunctive therapies as distal embolic protection devices in high risk
patients. Also, diabetic patients have higher incidence of compli-
cated coronary lesions, higher syntax score and they are more labile
for PMI.
http://dx.doi.org/10.1016/j.ehj.2013.12.052
Predictors of myocardial injury in patients with acute upper gastroin-
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UPPER gastrointestinal bleeding (UGIB) is a common, potentially
life-threatening condition. Myocardial injury may complicate UGIB.
Previous studies were conducted to evaluate causes and consequences
of UGIB after acute myocardial infarction (AMI). Acute MI adds
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